vs
AstroNova, Inc.（ALOT）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
AstroNova, Inc.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.1倍（$39.2M vs $35.5M），AstroNova, Inc.净利率更高（1.0% vs -304.2%，领先305.2%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -3.4%），AstroNova, Inc.自由现金流更多（$3.3M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 2.1%）
AstroNova是一家全球化科技企业，主打专业数据可视化产品与解决方案，核心产品包括高性能标签打印机、测试测量设备、航空级数据记录系统，服务航空航天、工业制造、零售、医疗等多个领域，客户遍及全球主要市场。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
ALOT vs RXRX — 直观对比
营收规模更大
ALOT
是对方的1.1倍
$35.5M
营收增速更快
RXRX
高出685.1%
-3.4%
净利率更高
ALOT
高出305.2%
-304.2%
自由现金流更多
ALOT
多$50.7M
$-47.3M
两年增速更快
RXRX
近两年复合增速
2.1%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $39.2M | $35.5M |
| 净利润 | $378.0K | $-108.1M |
| 毛利率 | 36.2% | 59.8% |
| 营业利润率 | 3.3% | -304.8% |
| 净利率 | 1.0% | -304.2% |
| 营收同比 | -3.4% | 681.7% |
| 净利润同比 | 221.5% | 39.6% |
| 每股收益（稀释后） | $0.05 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALOTRXRX
| Q4 25 | $39.2M | $35.5M | ||
| Q3 25 | $36.1M | $5.2M | ||
| Q2 25 | $37.7M | $19.2M | ||
| Q1 25 | — | $14.7M | ||
| Q4 24 | $40.4M | $4.5M | ||
| Q3 24 | $40.5M | $26.1M | ||
| Q2 24 | $33.0M | $14.4M | ||
| Q1 24 | $39.6M | $13.8M |
净利润ALOTRXRX
| Q4 25 | $378.0K | $-108.1M | ||
| Q3 25 | $-1.2M | $-162.3M | ||
| Q2 25 | $-376.0K | $-171.9M | ||
| Q1 25 | — | $-202.5M | ||
| Q4 24 | $240.0K | $-178.9M | ||
| Q3 24 | $-311.0K | $-95.8M | ||
| Q2 24 | $1.2M | $-97.5M | ||
| Q1 24 | $2.7M | $-91.4M |
毛利率ALOTRXRX
| Q4 25 | 36.2% | 59.8% | ||
| Q3 25 | 32.2% | -183.8% | ||
| Q2 25 | 33.6% | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | 33.9% | -181.4% | ||
| Q3 24 | 35.3% | 53.7% | ||
| Q2 24 | 36.3% | 36.2% | ||
| Q1 24 | 31.9% | 19.1% |
营业利润率ALOTRXRX
| Q4 25 | 3.3% | -304.8% | ||
| Q3 25 | -2.0% | -3327.6% | ||
| Q2 25 | 1.5% | -916.8% | ||
| Q1 25 | — | -1297.9% | ||
| Q4 24 | 3.1% | -4042.4% | ||
| Q3 24 | 2.6% | -377.1% | ||
| Q2 24 | 4.1% | -697.4% | ||
| Q1 24 | 9.9% | -698.4% |
净利率ALOTRXRX
| Q4 25 | 1.0% | -304.2% | ||
| Q3 25 | -3.4% | -3135.3% | ||
| Q2 25 | -1.0% | -894.2% | ||
| Q1 25 | — | -1373.3% | ||
| Q4 24 | 0.6% | -3935.5% | ||
| Q3 24 | -0.8% | -367.5% | ||
| Q2 24 | 3.6% | -676.6% | ||
| Q1 24 | 6.8% | -662.4% |
每股收益（稀释后）ALOTRXRX
| Q4 25 | $0.05 | $-0.17 | ||
| Q3 25 | $-0.16 | $-0.36 | ||
| Q2 25 | $-0.05 | $-0.41 | ||
| Q1 25 | — | $-0.50 | ||
| Q4 24 | $0.03 | $-0.56 | ||
| Q3 24 | $-0.04 | $-0.34 | ||
| Q2 24 | $0.15 | $-0.40 | ||
| Q1 24 | $0.37 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.6M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $76.9M | $1.1B |
| 总资产 | $140.8M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资ALOTRXRX
| Q4 25 | $3.6M | $743.3M | ||
| Q3 25 | $3.9M | $659.8M | ||
| Q2 25 | $5.4M | $525.1M | ||
| Q1 25 | — | $500.5M | ||
| Q4 24 | $4.4M | $594.4M | ||
| Q3 24 | $4.8M | $427.6M | ||
| Q2 24 | $4.0M | $474.3M | ||
| Q1 24 | $4.5M | $296.3M |
总债务ALOTRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益ALOTRXRX
| Q4 25 | $76.9M | $1.1B | ||
| Q3 25 | $75.8M | $1.0B | ||
| Q2 25 | $76.6M | $919.1M | ||
| Q1 25 | — | $933.9M | ||
| Q4 24 | $92.2M | $1.0B | ||
| Q3 24 | $91.8M | $524.6M | ||
| Q2 24 | $91.2M | $584.4M | ||
| Q1 24 | $90.3M | $401.2M |
总资产ALOTRXRX
| Q4 25 | $140.8M | $1.5B | ||
| Q3 25 | $143.1M | $1.4B | ||
| Q2 25 | $150.3M | $1.3B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | $166.5M | $1.4B | ||
| Q3 24 | $169.0M | $726.5M | ||
| Q2 24 | $126.6M | $775.9M | ||
| Q1 24 | $133.3M | $557.8M |
负债/权益比ALOTRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.4M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $3.3M | $-47.3M |
| 自由现金流率自由现金流/营收 | 8.5% | -133.1% |
| 资本支出强度资本支出/营收 | 0.2% | 3.5% |
| 现金转化率经营现金流/净利润 | 9.05× | — |
| 过去12个月自由现金流最近4个季度 | $2.9M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流ALOTRXRX
| Q4 25 | $3.4M | $-46.1M | ||
| Q3 25 | $249.0K | $-117.4M | ||
| Q2 25 | $4.4M | $-76.4M | ||
| Q1 25 | — | $-132.0M | ||
| Q4 24 | $-4.7M | $-115.4M | ||
| Q3 24 | $162.0K | $-59.2M | ||
| Q2 24 | $6.9M | $-82.2M | ||
| Q1 24 | $6.5M | $-102.3M |
自由现金流ALOTRXRX
| Q4 25 | $3.3M | $-47.3M | ||
| Q3 25 | $202.0K | $-117.6M | ||
| Q2 25 | $4.3M | $-79.6M | ||
| Q1 25 | — | $-133.8M | ||
| Q4 24 | $-5.0M | $-116.7M | ||
| Q3 24 | $-176.0K | $-63.8M | ||
| Q2 24 | $6.4M | $-83.4M | ||
| Q1 24 | $6.0M | $-109.0M |
自由现金流率ALOTRXRX
| Q4 25 | 8.5% | -133.1% | ||
| Q3 25 | 0.6% | -2272.5% | ||
| Q2 25 | 11.5% | -413.9% | ||
| Q1 25 | — | -907.4% | ||
| Q4 24 | -12.4% | -2567.7% | ||
| Q3 24 | -0.4% | -244.6% | ||
| Q2 24 | 19.5% | -578.5% | ||
| Q1 24 | 15.3% | -789.9% |
资本支出强度ALOTRXRX
| Q4 25 | 0.2% | 3.5% | ||
| Q3 25 | 0.1% | 4.7% | ||
| Q2 25 | 0.2% | 16.4% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | 0.6% | 28.6% | ||
| Q3 24 | 0.8% | 17.5% | ||
| Q2 24 | 1.5% | 8.2% | ||
| Q1 24 | 1.0% | 48.2% |
现金转化率ALOTRXRX
| Q4 25 | 9.05× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -19.76× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.85× | — | ||
| Q1 24 | 2.38× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALOT
| Public Utilities Inventory Supplies | $20.6M | 53% |
| Hardware Products | $12.7M | 32% |
| Service And Other | $5.9M | 15% |
RXRX
暂无分部数据
